Half-year report · Q2

Period2024-04-01 → 2024-09-30
Filed2024-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥11.4bn2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥20.4bn2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥10.5bn2023-04-01 → 2023-09-30Cons.Net sales
Operating income¥1.9bn2024-04-01 → 2024-09-30Cons.Operating income
Operating income¥1.7bn2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income¥1.9bn2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥3.2bn2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.8bn2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax¥2.1bn2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax¥1.8bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)¥1.3bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.2bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.2bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income¥1.5bn2024-04-01 → 2024-09-30Cons.Profit loss
Net income¥1.2bn2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥32.6bnat 2024-09-30Cons.Assets
Total assets¥31.5bnat 2024-03-31Cons.Assets
Total assets¥30.1bnat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥8.2bnat 2024-09-30Cons.Liabilities
Total liabilities¥7.9bnat 2024-03-31Cons.Liabilities
Net assets / equity¥24.4bnat 2024-09-30Cons.Net assets
Net assets / equity¥23.6bnat 2024-03-31Cons.Net assets
Net assets / equity¥22.5bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥15.7bnat 2024-09-30Cons.Cash and deposits
Cash and deposits¥14.0bnat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥15.7bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥14.0bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥13.3bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥12.8bnat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow¥1.2bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥3.0bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.5bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow¥1.1bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥883m2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥149m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥703m2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥998m2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥985m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥170.42024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥280.512023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥155.762023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio70.3%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio70.7%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio71.0%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue2024-04-01 → 2024-09-30¥1.4bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue external2024-04-01 → 2024-09-30¥1.4bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentsegment profit2024-04-01 → 2024-09-30¥215m
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue2024-04-01 → 2024-09-30¥9.9bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue external2024-04-01 → 2024-09-30¥9.9bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentsegment profit2024-04-01 → 2024-09-30¥1.6bn
—segment totalrevenue2024-04-01 → 2024-09-30¥11.4bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥11.4bn
—segment totalsegment profit2024-04-01 → 2024-09-30¥1.9bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue2023-04-01 → 2023-09-30¥1.3bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue external2023-04-01 → 2023-09-30¥1.3bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentsegment profit2023-04-01 → 2023-09-30¥194m
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue2023-04-01 → 2023-09-30¥9.2bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue external2023-04-01 → 2023-09-30¥9.2bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentsegment profit2023-04-01 → 2023-09-30¥1.5bn
—segment totalrevenue2023-04-01 → 2023-09-30¥10.5bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥10.5bn
—segment totalsegment profit2023-04-01 → 2023-09-30¥1.7bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 506
ItemContextValueUnit
Interest and dividends income received ope cf inv cfPrior1YTDDuration18369000JPY
Interest and dividends income received ope cf inv cfCurrentYTDDuration30622000JPY
Proceeds from subsidy income2 ope cfPrior1YTDDuration1049000JPY
Proceeds from subsidy income2 ope cfCurrentYTDDuration-JPY
Interest expenses paid ope cf fin cfPrior1YTDDuration-1640000JPY
Interest expenses paid ope cf fin cfCurrentYTDDuration-787000JPY
Income taxes paid ope cfPrior1YTDDuration-495857000JPY
Income taxes paid ope cfCurrentYTDDuration-703950000JPY
Net cash provided by used in operating activitiesPrior1YTDDuration1493735000JPY
Net cash provided by used in operating activitiesCurrentYTDDuration1175508000JPY
Proceeds from withdrawal of time deposits inv cfPrior1YTDDuration-JPY
Proceeds from withdrawal of time deposits inv cfCurrentYTDDuration500000000JPY
Proceeds from redemption of securities inv cfPrior1YTDDuration-JPY
Proceeds from redemption of securities inv cfCurrentYTDDuration1000000000JPY
Purchase of investment securities inv cfPrior1YTDDuration-99900000JPY
Purchase of investment securities inv cfCurrentYTDDuration-400000000JPY
Proceeds from sales of investment securities inv cfPrior1YTDDuration72327000JPY
Proceeds from sales of investment securities inv cfCurrentYTDDuration203024000JPY
Purchase of property plant and equipment inv cfPrior1YTDDuration-227074000JPY
Purchase of property plant and equipment inv cfCurrentYTDDuration-171341000JPY
Proceeds from sales of property plant and equipment inv cfPrior1YTDDuration16243000JPY
Proceeds from sales of property plant and equipment inv cfCurrentYTDDuration18045000JPY
Purchase of intangible assets inv cfPrior1YTDDuration-4876000JPY
Purchase of intangible assets inv cfCurrentYTDDuration-34513000JPY
Proceeds from cancellation of insurance funds inv cfPrior1YTDDuration63482000JPY
Proceeds from cancellation of insurance funds inv cfCurrentYTDDuration-JPY
Other net inv cfPrior1YTDDuration30446000JPY
Other net inv cfCurrentYTDDuration8678000JPY
Net cash provided by used in investment activitiesPrior1YTDDuration-149350000JPY
Net cash provided by used in investment activitiesCurrentYTDDuration1123893000JPY
Cash dividends paid fin cfPrior1YTDDuration-970623000JPY
Cash dividends paid fin cfCurrentYTDDuration-687204000JPY
Other net fin cfPrior1YTDDuration-13927000JPY
Other net fin cfCurrentYTDDuration-15425000JPY
Net cash provided by used in financing activitiesPrior1YTDDuration-984550000JPY
Net cash provided by used in financing activitiesCurrentYTDDuration-702630000JPY
Effect of exchange rate change on cash and cash equivalentsPrior1YTDDuration114152000JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYTDDuration102779000JPY
Net increase decrease in cash and cash equivalentsPrior1YTDDuration473986000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration1699550000JPY
Cash and cash equivalentsPrior2YearInstant12795930000JPY
Cash and cash equivalentsPrior1YearInstant13959093000JPY
Cash and cash equivalentsPrior1QuarterInstant13269917000JPY
Cash and cash equivalentsCurrentQuarterInstant15658644000JPY
Sales commission sgaPrior1YTDDuration682950000JPY
Sales commission sgaCurrentYTDDuration651219000JPY
Advertising expenses sgaPrior1YTDDuration690298000JPY
Advertising expenses sgaCurrentYTDDuration801432000JPY
Provision for product warranties sgaPrior1YTDDuration35848000JPY
Provision for product warranties sgaCurrentYTDDuration24498000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass
balance sheet identityconsolidated 2024-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass